Characterization of serum matrix metalloproteinase 2/9 levels in patients with ascending aortic aneurysms.

about

Serum matrix metalloproteinase-9 is a valuable biomarker for identification of abdominal and thoracic aortic aneurysm: a case-control study

P2860

Q58101153-FB8BB5F8-9E1E-467C-9252-29280182EB17

P2860

Characterization of serum matrix metalloproteinase 2/9 levels in patients with ascending aortic aneurysms.

Item

http://www.wikidata.org/entity/Q38818589

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Characterization of serum matr ...... th ascending aortic aneurysms.

@en

type

Item

label

Characterization of serum matr ...... th ascending aortic aneurysms.

@en

prefLabel

Characterization of serum matr ...... th ascending aortic aneurysms.

@en

P1476

Characterization of serum matr ...... th ascending aortic aneurysms.

@en

P2093

Anke Tscheuschler

http://www.w3.org/2001/XMLSchema#string

Bartosz Rylski

http://www.w3.org/2001/XMLSchema#string

Claudia Heilmann

http://www.w3.org/2001/XMLSchema#string

Fabian A Kari

http://www.w3.org/2001/XMLSchema#string

Nadja Kocher

http://www.w3.org/2001/XMLSchema#string

Philipp Discher

http://www.w3.org/2001/XMLSchema#string

Philipp Meffert

http://www.w3.org/2001/XMLSchema#string

Xenia Uffelmann

http://www.w3.org/2001/XMLSchema#string

P2860

Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaborat

Lessons on the pathogenesis of aneurysm from heritable conditions

Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome.

Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease.

Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

The rapid lipopolysaccharide-induced release of matrix metalloproteinases 9 is suppressed by simvastatin.

Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity.

Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.

Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors.

P304

20-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ICVTS/IVW309

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Friedhelm Beyersdorf

Matthias Siepe

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27659153

http://www.w3.org/2001/XMLSchema#string

Characterization of serum matrix metalloproteinase 2/9 levels in patients with ascending aortic aneurysms.

about

P2860

P2860

Characterization of serum matrix metalloproteinase 2/9 levels in patients with ascending aortic aneurysms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698